These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 28738940)
21. Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer. Parviz M; Cassel JB; Kaplan BJ; Karp SE; Neifeld JP; Penberthy LT; Bear HD J Surg Oncol; 2003 Oct; 84(2):57-62. PubMed ID: 14502777 [TBL] [Abstract][Full Text] [Related]
22. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer. Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341 [TBL] [Abstract][Full Text] [Related]
23. Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy. Christian N; Zabor EC; Cassidy M; Flynn J; Morrow M; Gemignani ML Ann Surg Oncol; 2020 Mar; 27(3):743-749. PubMed ID: 31732944 [TBL] [Abstract][Full Text] [Related]
24. Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer. Baskin AS; Wang T; Bredbeck BC; Sinco BR; Berlin NL; Dossett LA J Surg Res; 2021 Jun; 262():71-84. PubMed ID: 33548676 [TBL] [Abstract][Full Text] [Related]
25. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer. Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506 [TBL] [Abstract][Full Text] [Related]
26. Nationwide trends in mastectomy for early-stage breast cancer. Kummerow KL; Du L; Penson DF; Shyr Y; Hooks MA JAMA Surg; 2015 Jan; 150(1):9-16. PubMed ID: 25408966 [TBL] [Abstract][Full Text] [Related]
27. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. McGuire KP; Santillan AA; Kaur P; Meade T; Parbhoo J; Mathias M; Shamehdi C; Davis M; Ramos D; Cox CE Ann Surg Oncol; 2009 Oct; 16(10):2682-90. PubMed ID: 19653046 [TBL] [Abstract][Full Text] [Related]
28. Patterns of care with regard to surgical choice and application of adjuvant radiation therapy for preinvasive and early stage breast cancer in rural Appalachia. Freeman AB; Huang B; Dragun AE Am J Clin Oncol; 2012 Aug; 35(4):358-63. PubMed ID: 21422902 [TBL] [Abstract][Full Text] [Related]
29. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction. Koslow S; Pharmer LA; Scott AM; Stempel M; Morrow M; Pusic AL; King TA Ann Surg Oncol; 2013 Oct; 20(11):3422-9. PubMed ID: 23720070 [TBL] [Abstract][Full Text] [Related]
30. Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer. Metcalfe KA; Retrouvey H; Kerrebijn I; Butler K; O'Neill AC; Cil T; Zhong T; Hofer SOP; McCready DR Cancer; 2019 Nov; 125(22):3966-3973. PubMed ID: 31435939 [TBL] [Abstract][Full Text] [Related]
31. Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer? Adkisson CD; Bagaria SP; Parker AS; Bray JM; Gibson T; Thomas CS; Heckman MG; McLaughlin SA Ann Surg Oncol; 2012 Apr; 19(4):1129-36. PubMed ID: 21975859 [TBL] [Abstract][Full Text] [Related]
32. Rising Rates of Contralateral Prophylactic Mastectomy as a Treatment for Early-Stage Breast Cancer. Jerome-DʼEmilia B; Kushary D; Suplee PD Cancer Nurs; 2019; 42(1):12-19. PubMed ID: 29251681 [TBL] [Abstract][Full Text] [Related]
33. Social and Clinical Determinants of Contralateral Prophylactic Mastectomy. Hawley ST; Jagsi R; Morrow M; Janz NK; Hamilton A; Graff JJ; Katz SJ JAMA Surg; 2014 Jun; 149(6):582-9. PubMed ID: 24849045 [TBL] [Abstract][Full Text] [Related]
34. Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients. Tynan M; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill SC; Jandorf L; Kelly SP; Heinzmann J; Kelleher S; Poggi E; Schwartz MD Breast Cancer Res Treat; 2020 Feb; 180(1):177-185. PubMed ID: 31894446 [TBL] [Abstract][Full Text] [Related]
35. Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer. Katz SJ; Hawley ST; Hamilton AS; Ward KC; Morrow M; Jagsi R; Hofer TP JAMA Surg; 2018 Jan; 153(1):29-36. PubMed ID: 28903158 [TBL] [Abstract][Full Text] [Related]
36. Effect of preoperative MRI on mastectomy and contralateral prophylactic mastectomy rates at a community hospital by a single surgeon. Guilfoyle C; Christoudias M; Collett AE; Gracely EJ; Frazier TG; Barrio AV Breast J; 2014; 20(1):79-83. PubMed ID: 24438066 [TBL] [Abstract][Full Text] [Related]
37. Trends in Sexual Function After Breast Cancer Surgery. Cornell LF; Mussallem DM; Gibson TC; Diehl NN; Bagaria SP; McLaughlin SA Ann Surg Oncol; 2017 Sep; 24(9):2526-2538. PubMed ID: 28560595 [TBL] [Abstract][Full Text] [Related]
38. Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations. Xia C; Schroeder MC; Weigel RJ; Sugg SL; Thomas A Ann Surg Oncol; 2014 Dec; 21(13):4133-8. PubMed ID: 24934585 [TBL] [Abstract][Full Text] [Related]
39. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Graves KD; Peshkin BN; Halbert CH; DeMarco TA; Isaacs C; Schwartz MD Breast Cancer Res Treat; 2007 Sep; 104(3):321-9. PubMed ID: 17066320 [TBL] [Abstract][Full Text] [Related]
40. 'Taking control of cancer': understanding women's choice for mastectomy. Covelli AM; Baxter NN; Fitch MI; McCready DR; Wright FC Ann Surg Oncol; 2015 Feb; 22(2):383-91. PubMed ID: 25190120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]